Abstract 3847: The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study

Published 2015 View Full Article

Authors

Keywords

Journal

CANCER RESEARCH

Volume 74, Issue 19 Supplement, Pages 3847-3847

Publisher

American Association for Cancer Research (AACR)

Online

2015-05-06

DOI

10.1158/1538-7445.am2014-3847

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.